West Pharmaceutical Services, Inc. (WST) earnings
WST earnings moved a median of -1.23% by the close. Quarterly and annual WST reports and results, each read against the price at its own news timestamp. Back to the WST overview →
32 measured WST earnings events.
Where these WST earnings landedvs 32 measured WST earnings reactions
| Middle 50% of WST earnings reactions | -3.20% to +0.17% |
|---|---|
| Median reaction (to close) | -1.23% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 WST earnings events with a measured close landed between -3.20% and +0.17%; 28% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| West to Host Third-Quarter 2026 Conference Call | Press release | -0.04% | -0.65% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Jun 30 | SEC filing · Form 10-Q | -2.39% | -6.71% | |
| West Reports Second-Quarter 2026 Results | Press release | -5.03% | -7.67% | |
| West to Host Second-Quarter 2026 Conference Call | Press release | -0.75% | -1.22% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Mar 31 | SEC filing · Form 10-Q | -1.04% | -3.11% | |
| West Reports First-Quarter 2026 Results | Press release | -0.23% | -1.37% | |
| West to Host First-Quarter 2026 Conference Call | Press release | +0.05% | -2.21% | |
| Form 10-K WEST PHARMACEUTICAL SERV For: Dec 31 | SEC filing · Form 10-K | -0.30% | +0.69% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Sep 30 | SEC filing · Form 10-Q | +0.06% | -3.40% | |
| West Reports Third-Quarter 2025 Results | Press release | +7.16% | +2.42% | |
| West to Host Third-Quarter 2025 Conference Call | Press release | -0.22% | -1.56% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Jun 30 | SEC filing · Form 10-Q | -0.81% | -5.59% | |
| West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance | Press release | +0.64% | -1.13% | |
| West to Host Second-Quarter 2025 Conference Call | Press release | -0.12% | -0.69% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Mar 31 | SEC filing · Form 10-Q | -1.07% | -0.07% | |
| West Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend | Press release | -6.62% | -3.45% | |
| West to Host First-Quarter 2025 Conference Call | Press release | +0.09% | +0.61% | |
| Form 10-K WEST PHARMACEUTICAL SERV For: Dec 31 | SEC filing · Form 10-K | -0.92% | -4.03% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Sep 30 | SEC filing · Form 10-Q | -1.86% | -6.12% | |
| West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend | Press release | +3.63% | +0.02% | |
| West to Host Third-Quarter 2024 Conference Call | Press release | -0.28% | +0.98% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Jun 30 | SEC filing · Form 10-Q | -1.44% | +1.83% | |
| West Announces Second-Quarter 2024 Results | Press release | -4.37% | -1.27% | |
| West to Host Second-Quarter 2024 Conference Call | Press release | -0.01% | +2.66% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Mar 31 | SEC filing · Form 10-Q | +0.90% | -1.04% | |
| West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend | Press release | -3.57% | -5.67% | |
| West to Host First-Quarter 2024 Conference Call | Press release | +0.01% | -1.24% | |
| Form 10-K WEST PHARMACEUTICAL SERV For: Dec 31 | SEC filing · Form 10-K | +0.98% | +2.25% | |
| West Announces Second-Quarter 2024 Dividend | Press release | +0.94% | -3.13% | |
| West Announces First-Quarter 2024 Dividend | Press release | +0.20% | -0.60% | |
| Form 10-Q WEST PHARMACEUTICAL SERV For: Sep 30 | SEC filing · Form 10-Q | +0.42% | -1.48% | |
| West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend | Press release | -0.94% | +0.71% |
Keep exploring
More WST: analyst actions → · SEC filings → · WST overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 848 | -0.17% | 47% |
| Capital Senior Living Corporation (CSU) | 847 | 0.00% | 50% |
| Adamas Pharmaceuticals, Inc. (ADMS) | 846 | -0.16% | 44% |
| Defiance Daily Target 2x Long LMND ETF (LMNX) | 844 | +0.07% | 54% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.